Study of the out-of-field dose from an accelerator-based neutron source for boron neutron capture therapy
Metadatos
Afficher la notice complèteAuteur
Verdera, Antònia; Torres Sánchez, Pablo; Praena Rodríguez, Antonio Javier; Porras Sánchez, José IgnacioEditorial
Elsevier
Materia
BNCT Neutrons Out-of-field
Date
2024-07-27Referencia bibliográfica
Verdera, A. et. al. 212 (2024) 111458. [https://doi.org/10.1016/j.apradiso.2024.111458]
Patrocinador
Spanish Ministerio de Ciencia e Innovación (Proyectos de I+D+i: PID2020-117969RB-I00); Junta de Andalucía, Spain (Andalusian Regional Government, P20-00665 and Programa Operativo FEDER Andalucia 2014–2020 under contracts A-FQM-371-UGR18, B-FQM- 156-UGR20); Spanish La Caixa Foundation; University Chair ‘‘Neutrons for Medicine’’: Fundación ACS, Capitán Antonio, La Kuadrilla de Iznalloz, Sonriendo se Puede Ganar and Costaleros Contra el Cáncer, SpaiRésumé
One important issue in Boron Neutron Capture Therapy is the delivered dose to the tissues outside the tumor.
An international standard for light ion beam systems sets two recommended limits for out-of-field dose based
on distance from the field edge: maximum absorbed dose from all radiation types shall not exceed 0.5 % of
the maximum dose at distances 15 cm to 50 cm from the field edge. At distances > 50 cm from the field
edge, the maximum absorbed dose shall not exceed 0.1 %. This paper is a continuation of our previous works
focused on the design of an accelerator-based neutron source for BNCT. We already designed a novel Beam
Shape Assembly which meets the IAEA criteria for BNCT treatments. Using this BSA, in the present work, we
characterize by Monte Carlo simulations the dose outside the neutron field. The out-of-field dose has been
assessed via estimates using the ambient and equivalent dose. Also the boron uptake in healthy tissues has
been analyzed for the equivalent dose computation. It is concluded that our design for a future acceleratorbased
source for BNCT meets reasonably well the criteria defined from other forms of radiotherapy on both
equivalent and effective dose outside the field.